Skip to main content

10X Fund, L.P.'s Form 4/A amendment

Amended

Galectin Therapeutics Inc (GALT) · filed Aug 15, 2022

Accession no.
0001493152-22-022804
Filed
Aug 15, 2022
Trade date
Jul 27, 2022
Filing delay
19 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Aug 9, 2022

This filing lists 1 non-derivative transaction. Open-market sales total $20.9K. It was filed 19 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
10X Fund, L.P.CIK 000145335610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 27, 2022Common StockSSaleDisposed−10,000$2.09−$20,9006,168,940Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Shares sold pursuant to 10X Fund, LP's Rule 10b5-1 trading plan.

F2

10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P., but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. James C. Czirr is the manager of 10X Capital Management, LLC, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. and 10X Capital Management, LLC., but disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Read the full filing on SEC EDGAR (opens in a new tab)